BioRegenx, Inc.
BRGX
$0.01
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 97.41% | -1,162.78% | 54.80% | 33.20% | 98.55% |
| Total Depreciation and Amortization | -65.96% | 400.79% | -133.69% | 201.61% | -97.84% |
| Total Amortization of Deferred Charges | -- | -192.59% | 2,350.00% | -180.00% | -90.74% |
| Total Other Non-Cash Items | -105.49% | 909.07% | -10.06% | 3.40% | -99.48% |
| Change in Net Operating Assets | -60.01% | 341.20% | -277.41% | -74.46% | 44.73% |
| Cash from Operations | -61.78% | 197.21% | -2,337.50% | -91.51% | 430.70% |
| Capital Expenditure | -- | 48.33% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Investing | -- | 48.33% | 88.00% | -- | -- |
| Total Debt Issued | -- | -100.00% | 291.67% | -- | -- |
| Total Debt Repaid | -26.98% | 5.57% | -253.79% | -26.92% | -22.35% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -13.83% | -162.29% | 321.43% | 261.54% | -50.72% |
| Foreign Exchange rate Adjustments | -- | -100.00% | 200.00% | -242.86% | -152.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -205.36% | 4,380.00% | 101.34% | -247.62% | 315.38% |